TrialPhase 2b Imaging Study of RAD101 in Participants With Suspected Recurrent Brain Metastases
Trial details
- Registry ID
- NCT06777433
- Phase
- Phase 2
RADX
Radiopharm Theranostics, Ltd
Company identity checked against sources
Browse linked trials and recorded changes, or follow this company for updates.
1Trials in this database
3Recorded changes · last 12 months
Partial coverageOnly the trials and history collected so far
Research sample: selected versions from May 2023 onward plus a preceding baseline where available. Only selected fields were retained; endpoint measures were truncated to 300 characters. This is not complete trial or sponsor history. Daily snapshots begin when collection starts.
Completion dates · Pro
Which trial dates moved later?
Pro summarizes how far estimated completion dates moved later and counts trials with edits to their main study measures, using the history available here. View Pro features
Included trials
Check company identity source| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Phase 2b Imaging Study of RAD101 in Participants With Suspected Recurrent Brain MetastasesNCT06777433 | RADX | Phase 2 | Active not recruiting | 2026-04-23Actual |
Latest recorded trial changes
Phase 2b Imaging Study of RAD101 in Participants With Suspected Recurrent Brain Metastases
NCT06777433 · Radiopharm Theranostics, Ltd
Completion date type changed
− Before
Estimated
+ After
Actual
Primary completion date changed
− Before
Jan 2026
+ After
23 Apr 2026
Recruitment status changed
− Before
Recruiting
+ After
Active not recruiting